Left Menu
Development News Edition

Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-19 patients

Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.

ANI | Mumbai (Maharashtra) | Updated: 29-05-2020 15:40 IST | Created: 29-05-2020 15:40 IST
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-19 patients
The company has 42 manufacturing facilities across six continents. Image Credit: ANI

Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients. Nafamostat is approved in Japan for improvement of acute symptoms of pancreatitis and treatment of disseminated intravascular coagulation (DIC).

A group of scientists from the University of Tokyo in Japan and Leibniz Institute for Primate Research inGermany recently demonstrated that Nafamostat at very low concentrations suppresses a protein (TMPRSS2) that the Covid-19 virus uses to enter human lung cells. Another group from Institut Pasteur in South Korea also published data comparing antiviral efficacy of 24 drugs and Nafamostat against SARSCoV-2 in in-vitro studies in human lung epithelial derived cells.

In this research, Nafamostat was found to be the most potent drug and was able to inhibit virus entry at very low concentrations, consistent with findings from Japan and German labs. Globally, there are three clinical trials currently underway to test Nafamostat in Covid-19 patients. Thesetrials are being led by the University of Tokyo Hospital in Japan, Gyeongsang National University Hospital in South Korea, and a collaborative trial by University Hospital at Padova in Italy, University of Zurich inSwitzerland and Yokohoma City University in Japan.

Considering the pandemic situation and urgent need for newer treatment options, Sun Pharma plans toinitiate the clinical trials at the earliest. The company has initiated manufacturing of both, the active pharma ingredient and the finished product of Nafamostat in India, using technology from its subsidiary, Pola Pharma Japan. "Sun Pharma is constantly evaluating potential targets that can be explored for treating Covid-19 patients," said Managing Director Dilip Shanghvi.

"Nafamostat has shown promising data against SARS-CoV-2 virus in in vitro studies conducted by three independent groups of scientists in Europe, Japan and South Korea. We believe it holds promise in the treatment of Covid-19 patients," he said in a statement. Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Delivering products for customers and patients in over 100 countries, its global presence is supported by manufacturing facilities spread across six continents which are approved by multiple regulatory agencies. (ANI)


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

U.S. appeals court says first federal execution in 17 years can proceed Monday

The first federal execution in 17 years is set to go ahead on Monday after a U.S. appeals court overturned a lower court injunction, saying a lawsuit by the victims family that had put the execution on hold had no legal standing.Daniel Lewi...

Former All-Star 2B Bolling dies at 88

Former two-time All-Star second baseman Frank Bolling has died. He was 88. Bolling died Saturday in his hometown of Mobile, Ala., according to multiple reports. He was battling cancer.Bolling played 12 major league seasons from 1954-66 and ...

Coronavirus bringing record $1 trillion of new global corporate debt in 2020- report

Companies around the world will take on as much as 1 trillion of new debt in 2020, as they try to shore up their finances against the coronavirus, a new study of 900 top firms has estimated.The unprecedented increase will see total global c...

Incumbent Duda extends narrow lead in Polish election cliffhanger

Incumbent Andrzej Dudas marginal lead in Polands presidential election was widening, a late poll showed on Sunday, a result, which while still uncertain, could have profound implications for Warsaws relations with the European Union. The la...

Give Feedback